HK Stock Market Move | CHEERWIN GP (06601) rose more than 4%. The interim profit attributable to owners increased by more than 20% year-on-year. The company experienced rapid growth across all channels.
Chaoyun Group (06601) rose by over 4%. As of the time of reporting, it has increased by 3.36%, trading at HKD 2.305, with a transaction volume of HKD 9.2767 million.
CHEERWIN GP (06601) rose over 4%, and as of the time of writing, it is up 3.36%, trading at HKD 2.305, with a turnover of HKD 9.2767 million.
In news, on August 25, CHEERWIN GP announced its interim results for 2026, with revenue of approximately RMB 1.635 billion, a year-on-year increase of 22.1%; the profit attributable to shareholders was about RMB 212 million, a year-on-year increase of 22.24%; earnings per share stood at 15.91 cents, with an interim dividend of HKD 0.0636 per share.
The announcement stated that the company has experienced rapid growth across all channels: a high-quality and sustainable channel marketing strategy was developed based on profitability. The online channels benefited from the rapid growth of emerging e-commerce platforms like Douyin and direct sales channels, resulting in a 27.3% growth in revenue from online channels compared to the six months ending June 30, 2025; revenue from offline channels increased by 18.9% during the reporting period compared to the same six months; the pet business achieved a 15.3% revenue growth during the reporting period compared to the six months ending June 30, 2025, through the creation of successful pet food and supplies combinations across multiple online categories and platforms, while enhancing the operational quality and service standards of offline stores.
Related Articles
Bank of America Securities: Downgraded HAIDILAO (06862) target price to HKD 12.3, half-year results generally in line with expectations.

Lyon: Raises the target price of REMEGEN (09995) to HK$144.8, maintains "Outperform" rating.

Lyon: Maintain the "Outperform Market" rating for CHINARES PHARMA (03320), with a target price revised down to HKD 6.5.
Bank of America Securities: Downgraded HAIDILAO (06862) target price to HKD 12.3, half-year results generally in line with expectations.
Lyon: Raises the target price of REMEGEN (09995) to HK$144.8, maintains "Outperform" rating.

Lyon: Maintain the "Outperform Market" rating for CHINARES PHARMA (03320), with a target price revised down to HKD 6.5.

RECOMMEND





